ACRN Therapy for Tinnitus: Acoustic Coordinated Reset Neuromodulation Explained
ACRN is one of the most theoretically elegant interventions in tinnitus research. By delivering four carefully-pitched tones in a random sequence, it attempts to break up the synchronised neural oscillations that many researchers believe drive chronic tinnitus. Here is what the science says — and what it doesn’t.
This article is for informational purposes only. Tinnitus can have medically significant causes. Consult an audiologist or ENT before starting any sound therapy programme.
The Neural Synchrony Hypothesis
Most current neuroscience models of chronic tinnitus converge on one observation: in people with persistent tinnitus, auditory neurons at the tinnitus frequency fire in abnormal synchrony. Under normal conditions, the millions of neurons in the auditory cortex fire with some independence; their combined output codes for sound in the environment. In tinnitus, a population of neurons — those tuned to the tinnitus frequency — begin firing together in lock-step, generating a persistent signal that the brain interprets as sound even when none is present.
This is not merely a local phenomenon. EEG and MEG studies (Weisz et al., 2007; Llinas et al., 1999) show that tinnitus is associated with altered oscillatory dynamics across the auditory cortex and beyond — including aberrant alpha and delta wave activity. The synchrony is self-reinforcing: neurons that fire together strengthen their connections (Hebbian plasticity), making the phantom signal increasingly stable over time.
In chronic tinnitus, a population of auditory neurons fires in persistent synchrony at the tinnitus frequency. ACRN attempts to break this synchrony by delivering precisely-timed acoustic stimuli that progressively desynchronise the abnormal oscillation.
ACRN, developed by physicist Peter Tass and colleagues at the Forschungszentrum Jülich, applies a principle from nonlinear dynamics: coordinated reset stimulation. This technique was originally developed for deep brain stimulation in Parkinson’s disease — where a similar pathological synchrony exists in motor circuits — and was subsequently adapted for acoustic delivery in tinnitus.
The ACRN Protocol: Four Tones and Why They Matter
The ACRN protocol uses four tones at specific frequency ratios relative to the tinnitus pitch. In the original Tass formulation, these are placed at:
- 0.773 × tinnitus frequency
- 0.909 × tinnitus frequency
- 1.091 × tinnitus frequency
- 1.295 × tinnitus frequency
These ratios are not arbitrary. They are derived mathematically to maximise the desynchronising effect on a network of coupled oscillators. Tones placed too close to the tinnitus frequency would entrain the neural network further; tones placed too far away would have no effect. The specific ratios hit the “sweet spot” where each tone disrupts the synchronised firing of a subset of the network, and the combined random sequence progressively breaks the overall synchrony.
Delivery and randomisation
The four tones are delivered in a quasi-random order, with each tone approximately 250–500 ms in duration. The randomisation is critical: a fixed sequence would risk re-entraining the neural network in a new pattern. Randomness prevents any new stable attractor from forming.
Clinical Evidence
The evidence base for ACRN is smaller than for notched sound therapy but growing, with several peer-reviewed studies demonstrating meaningful effects.
Key studies
- Tass PA et al. (2012) — Frontiers in Neurology: The foundational RCT (n=63). After 12 weeks of daily ACRN, the treatment group showed significant reductions in Tinnitus Handicap Inventory (THI) scores and audiometric tinnitus loudness versus sham. Critically, the effect persisted at 4-week follow-up, suggesting lasting neural change rather than temporary masking.
- Silchenko AN et al. (2013) — PLOS Computational Biology: Computational modelling study confirming that the specific tone ratios produce optimal desynchronisation in simulated tinnitus networks, validating the theoretical basis.
- Hauptmann C, et al. (2017): Follow-up study showing that 6-month home use of ACRN continued to show benefits, with approximately 50% of patients reporting clinically significant improvement.
- Multiple small trials (2018–2024): Broadly replicate modest-to-moderate improvements in THI and tinnitus loudness. Effect sizes vary considerably, likely due to frequency calibration accuracy and compliance differences.
Where the evidence is weaker
Sham-controlled trials with rigorous blinding are difficult to conduct for acoustic interventions (participants can often detect which tones are near their tinnitus). Some studies have shown no significant difference from active control conditions. The optimal session duration, daily dose, and total treatment length remain under investigation.
Who Benefits Most From ACRN?
ACRN clinical trials and observational data suggest the following patient characteristics are associated with better outcomes:
- Tonal tinnitus with a clearly identifiable single pitch (not multi-tonal or broadband noise-like tinnitus)
- High-frequency tinnitus in the 4,000–10,000 Hz range
- Associated hearing loss in the tinnitus frequency region
- Moderate-to-severe tinnitus distress (THI > 38) — mild cases may not show statistically significant improvement over natural fluctuation
- Ability to accurately match tinnitus pitch — frequency calibration accuracy directly impacts outcomes
In Tinnitus Wizard, ACRN unlocks at Week 3 of the programme. The first two weeks of Foundation sessions prime the auditory system and establish consistent listening habits before introducing the more complex ACRN stimulus.
How to Use ACRN in Tinnitus Wizard
Tinnitus Wizard implements the full ACRN protocol with calibrated frequency ratios based on your individual tinnitus pitch.
- Calibrate your frequency first (Calibrate tab). ACRN is highly frequency-specific — even a 500 Hz error reduces effectiveness significantly.
- Complete Foundation sessions for 2 weeks before switching to ACRN. This is not an arbitrary restriction: Foundation notched noise primes lateral inhibition and stabilises the neural environment.
- Start sessions at low volume. ACRN involves four tones that some people initially find intrusive. Begin at 15–20% volume and adjust upward over several days.
- Target 60–90 minutes daily. The Tass protocol used 3×daily 20-minute sessions; continuous use is also effective.
- Measure your response. Run the Residual Inhibition Test weekly and monitor your Tinnitus Handicap Inventory score. Changes are slow; expect 8–12 weeks before significant improvement.
Realistic Expectations and Timelines
| Timeframe | What to Expect |
|---|---|
| Week 1–2 | Familiarisation. Some people find the tones irritating at first. Persistence through this phase is important. |
| Week 3–6 | First signs of reduced tinnitus intrusiveness may appear. Loudness changes are typically not yet measurable. |
| Week 8–12 | The key assessment window. Clinically meaningful responders typically show THI reduction of ≥7 points by week 12. |
| Month 4–6 | Continued improvement in responders. Some partial responders continue to improve beyond 12 weeks. |
| Non-responders | ~40–50% of users see no significant audiometric change. Subjective quality-of-life improvements are sometimes reported even in audiometric non-responders. |
ACRN vs Notched Noise vs Bimodal: How They Compare
| Approach | Mechanism | Evidence Level | Best For |
|---|---|---|---|
| Notched noise | Lateral inhibition via frequency-specific suppression | Strongest (multiple RCTs) | Most tinnitus profiles; entry-level therapy |
| ACRN | Neural desynchronisation via coordinated reset | Moderate (several RCTs) | Tonal, high-frequency tinnitus with measurable pitch |
| Bimodal | Multisensory neural plasticity; DCN rebalancing | Moderate (Shore et al.) | Tinnitus with somatosensory modulation component |
These approaches are not mutually exclusive. Tinnitus Wizard’s programme structure introduces them sequentially, allowing each to prime the neural environment for the next.
- ACRN targets the neural synchrony underlying chronic tinnitus by delivering four tones at precise frequency ratios around the tinnitus pitch in a random sequence.
- The mechanism is derived from nonlinear dynamics and coordinated reset theory, originally developed for Parkinson’s tremor.
- Clinical evidence shows meaningful improvement in approximately 50% of appropriately selected patients after 12+ weeks.
- Frequency accuracy is critical: miscalibration by even 500 Hz significantly reduces effectiveness.
- ACRN works best after a period of Foundation (notched noise) sessions and is most effective for clearly tonal, high-frequency tinnitus.
Start Your ACRN Programme
Tinnitus Wizard delivers calibrated ACRN sessions with the correct frequency ratios for your tinnitus. Unlocks at Week 3 of the programme.
Open Tinnitus Wizard →Editorial standards
Tinnitus Wizard articles are written and maintained by our editorial team. We are not a medical practice and these articles are not authored by a clinician. Every clinical statement is sourced from peer-reviewed research, listed in the References section, and we describe both the evidence and its limitations honestly — including where a method is weaker or less proven than it is often marketed to be. Articles are reviewed against the current literature and dated; the last review date appears in the byline. Nothing here is a diagnosis or treatment recommendation. If your tinnitus is new, sudden, one-sided, or accompanied by hearing loss or dizziness, see an audiologist or ENT physician.
References
- Tass PA, et al. (2012). Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restorative Neurology and Neuroscience, 30(2), 137–159.
- Silchenko AN, et al. (2013). Data-driven approach to desynchronization of coupled neuron models. PLOS Computational Biology.
- Hauptmann C, et al. (2017). Acoustic coordinated reset neuromodulation in a real life patient population with chronic tonal tinnitus. BioMed Research International.
- Weisz N, et al. (2007). The neural code of auditory phantom perception. Journal of Neuroscience, 27(6), 1479–1484.
- Llinas R, et al. (1999). Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. PNAS, 96(26), 15222–15227.